Delivery Order SPE2DB24D3014-SPE2DB25FKTGR
Award Date
4/30/25
Potential Completion Date
5/1/25
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENBREL 50 MG/ML syringes, a medication used to treat certain autoimmune disorders. The contract has a firm fixed price, a ceiling value of $65,732.01, and a period of performance through April 17, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp also holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,385.99, is for the supply of Enbrel 50 mg/mL syringes, a specialty medication used for various medical conditions. The contract has a firm fixed price pricing type and runs through March 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ENBREL 25 MG/0.5 ML syringes, a specialty pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $6,067.06, and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SYRINGEML. The contract has a ceiling value of $61,017.59 and a period of performance through October 6, 2023. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a $33,967.47 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Enbrel 50 mg/mL syringes, a specialty medication used to treat various autoimmune conditions. The contract is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company. The contract is for the supply of Enbrel 50 mg/mL syringes, with a ceiling value of $17,891.90 and a performance period through March 25, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical with a potential...
This is a $12,243.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SYRINGEML, a specialty medication, with a period of performance through February 14, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp for the supply of ENBREL 50 MG/ML SYRINGEML. The contract, valued at $8,972.76, has a period of performance through September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of pharmaceutical and...
This is a federal delivery order contract awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Enbrel 25 mg/0.5 ml vials, a biologic medication used to treat various autoimmune conditions. The fixed-price contract has a ceiling value of $7,528.95 and an ultimate completion date of May 17, 2024. Amerisourcebergen has a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a $18,058.07 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SYRINGEML, a medication used to treat certain inflammatory conditions. The contract has an ultimate completion date of April 9, 2025 and was awarded on April 8, 2025. There is no set-aside designation for this...